Our Portfolio

Grade 2 began in the form of "brand partnerships" within Two Blind Brothers and biotechnology companies that shared our same audience in retinal eye disease.  These partnerships originally centered around marketing, events, and patient education.​

​

Since then, we've  been able to contribute more to our partners as a patient community, 1st-party data source, and public advocate. We further create alignment by investing our own capital in our partners. Our mission is to drive value both for the portfolio and for the patients and consumers through accelerating our partners' innovative products and therapies.